Are pharmacists and pharmaceutical care having an impact on diabetes?

M. J. Monaghan, Michael S. Monaghan

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

This study sought to identify pharmacy services offered to patients with diabetes and demonstrate patients receiving pharmaceutical care services had better glucose control as measured by laboratory values and medication compliance. Two hundred randomly selected patients with diabetes were identified from a pharmacy benefits manager's database. Their pharmacists were mailed a survey requesting information concerning morbidity risk factors, concomitant disease states, concomitant medications, diabetes pharmacotherapy, blood glucose concentrations, and percent hemoglobin A1c values. Information concerning diabetes cognitive services offered was also requested. A statistically significant correlation between diabetes cognitive services and improved disease control was not demonstrated secondarily to the small number of responses returned with glucose control information. Our results indicate pharmacists must improve documentation of their services and the impact these interventions have on disease control in order to prepare for reimbursement for cognitive services.

Original languageEnglish
Pages (from-to)8-16
Number of pages9
JournalPharmacy practice management quarterly
Volume17
Issue number4
StatePublished - 1998

Fingerprint

Pharmaceutical Services
Pharmacists
Glucose
Medication Adherence
Documentation
Blood Glucose
Hemoglobins
Databases
Morbidity
Drug Therapy

Cite this

Are pharmacists and pharmaceutical care having an impact on diabetes? / Monaghan, M. J.; Monaghan, Michael S.

In: Pharmacy practice management quarterly, Vol. 17, No. 4, 1998, p. 8-16.

Research output: Contribution to journalArticle

@article{4d522d18ff274b93ad30408df1525451,
title = "Are pharmacists and pharmaceutical care having an impact on diabetes?",
abstract = "This study sought to identify pharmacy services offered to patients with diabetes and demonstrate patients receiving pharmaceutical care services had better glucose control as measured by laboratory values and medication compliance. Two hundred randomly selected patients with diabetes were identified from a pharmacy benefits manager's database. Their pharmacists were mailed a survey requesting information concerning morbidity risk factors, concomitant disease states, concomitant medications, diabetes pharmacotherapy, blood glucose concentrations, and percent hemoglobin A1c values. Information concerning diabetes cognitive services offered was also requested. A statistically significant correlation between diabetes cognitive services and improved disease control was not demonstrated secondarily to the small number of responses returned with glucose control information. Our results indicate pharmacists must improve documentation of their services and the impact these interventions have on disease control in order to prepare for reimbursement for cognitive services.",
author = "Monaghan, {M. J.} and Monaghan, {Michael S.}",
year = "1998",
language = "English",
volume = "17",
pages = "8--16",
journal = "Pharmacy practice management quarterly",
issn = "1080-5737",
publisher = "Aspen Publishers Inc.",
number = "4",

}

TY - JOUR

T1 - Are pharmacists and pharmaceutical care having an impact on diabetes?

AU - Monaghan, M. J.

AU - Monaghan, Michael S.

PY - 1998

Y1 - 1998

N2 - This study sought to identify pharmacy services offered to patients with diabetes and demonstrate patients receiving pharmaceutical care services had better glucose control as measured by laboratory values and medication compliance. Two hundred randomly selected patients with diabetes were identified from a pharmacy benefits manager's database. Their pharmacists were mailed a survey requesting information concerning morbidity risk factors, concomitant disease states, concomitant medications, diabetes pharmacotherapy, blood glucose concentrations, and percent hemoglobin A1c values. Information concerning diabetes cognitive services offered was also requested. A statistically significant correlation between diabetes cognitive services and improved disease control was not demonstrated secondarily to the small number of responses returned with glucose control information. Our results indicate pharmacists must improve documentation of their services and the impact these interventions have on disease control in order to prepare for reimbursement for cognitive services.

AB - This study sought to identify pharmacy services offered to patients with diabetes and demonstrate patients receiving pharmaceutical care services had better glucose control as measured by laboratory values and medication compliance. Two hundred randomly selected patients with diabetes were identified from a pharmacy benefits manager's database. Their pharmacists were mailed a survey requesting information concerning morbidity risk factors, concomitant disease states, concomitant medications, diabetes pharmacotherapy, blood glucose concentrations, and percent hemoglobin A1c values. Information concerning diabetes cognitive services offered was also requested. A statistically significant correlation between diabetes cognitive services and improved disease control was not demonstrated secondarily to the small number of responses returned with glucose control information. Our results indicate pharmacists must improve documentation of their services and the impact these interventions have on disease control in order to prepare for reimbursement for cognitive services.

UR - http://www.scopus.com/inward/record.url?scp=0031602608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031602608&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 8

EP - 16

JO - Pharmacy practice management quarterly

JF - Pharmacy practice management quarterly

SN - 1080-5737

IS - 4

ER -